DE602007012281D1 - Substituierte amide, herstellungsverfahren und verwendungsverfahren - Google Patents
Substituierte amide, herstellungsverfahren und verwendungsverfahrenInfo
- Publication number
- DE602007012281D1 DE602007012281D1 DE602007012281T DE602007012281T DE602007012281D1 DE 602007012281 D1 DE602007012281 D1 DE 602007012281D1 DE 602007012281 T DE602007012281 T DE 602007012281T DE 602007012281 T DE602007012281 T DE 602007012281T DE 602007012281 D1 DE602007012281 D1 DE 602007012281D1
- Authority
- DE
- Germany
- Prior art keywords
- preparation
- substituted amides
- use method
- amides
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84383306P | 2006-09-11 | 2006-09-11 | |
| PCT/US2007/078185 WO2008033857A2 (en) | 2006-09-11 | 2007-09-11 | Substituted amides, method of making, and method of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602007012281D1 true DE602007012281D1 (de) | 2011-03-10 |
Family
ID=39184519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602007012281T Active DE602007012281D1 (de) | 2006-09-11 | 2007-09-11 | Substituierte amide, herstellungsverfahren und verwendungsverfahren |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP2079726B1 (de) |
| JP (1) | JP5563301B2 (de) |
| KR (1) | KR101444481B1 (de) |
| CN (1) | CN101605778A (de) |
| AR (1) | AR063707A1 (de) |
| AT (1) | ATE496909T1 (de) |
| AU (1) | AU2007296563B2 (de) |
| BR (1) | BRPI0716914A2 (de) |
| CA (1) | CA2661951C (de) |
| CL (1) | CL2007002642A1 (de) |
| CO (1) | CO6180464A2 (de) |
| CR (1) | CR10709A (de) |
| DE (1) | DE602007012281D1 (de) |
| EC (1) | ECSP099238A (de) |
| ES (1) | ES2363269T3 (de) |
| IL (1) | IL197264A0 (de) |
| MA (1) | MA31276B1 (de) |
| MX (1) | MX2009002651A (de) |
| NO (1) | NO20091426L (de) |
| PE (1) | PE20081370A1 (de) |
| RU (1) | RU2009113692A (de) |
| TW (1) | TWI398439B (de) |
| WO (1) | WO2008033857A2 (de) |
| ZA (1) | ZA200901634B (de) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR063706A1 (es) * | 2006-09-11 | 2009-02-11 | Cgi Pharmaceuticals Inc | Determinadas amidas sustituidas, el uso de las mismas para el tratamiento de enfermedades mediadas por la inhibicion de la actividad de btk y composiciones farmaceuticas que las comprenden. |
| JP5587193B2 (ja) | 2007-10-23 | 2014-09-10 | エフ．ホフマン−ラ ロシュ アーゲー | 新規なキナーゼ阻害剤 |
| US7683064B2 (en) | 2008-02-05 | 2010-03-23 | Roche Palo Alto Llc | Inhibitors of Bruton's tyrosine kinase |
| EP2297105B1 (de) * | 2008-05-06 | 2015-09-02 | Gilead Connecticut, Inc. | Substituierte amide, methode zur herstellung, und verwendung als btk inhibitoren |
| PE20100851A1 (es) | 2008-06-24 | 2011-01-31 | Hoffmann La Roche | PIRIDIN-2-ONAS Y PIRIDAZIN-3-ONAS SUSTITUIDAS COMO INHIBIDORES DE Btk |
| EP2300459B1 (de) | 2008-07-02 | 2013-05-29 | F. Hoffmann-La Roche AG | Neue phenylpyrazinone als kinasehemmer |
| US8299077B2 (en) * | 2009-03-02 | 2012-10-30 | Roche Palo Alto Llc | Inhibitors of Bruton's tyrosine kinase |
| AR082590A1 (es) | 2010-08-12 | 2012-12-19 | Hoffmann La Roche | Inhibidores de la tirosina-quinasa de bruton |
| CN104704129A (zh) | 2012-07-24 | 2015-06-10 | 药品循环公司 | 与对布鲁顿酪氨酸激酶(btk)抑制剂的抗性相关的突变 |
| DK2989106T3 (en) | 2013-04-25 | 2017-03-20 | Beigene Ltd | CONDENSED HETEROCYCLIC COMPOUNDS AS PROTEINKINASE INHIBITORS |
| CN104177338B (zh) * | 2013-05-22 | 2018-04-03 | 南京勇山生物科技有限公司 | 一类布鲁顿激酶抑制剂 |
| CN107011441B (zh) | 2013-09-13 | 2020-12-01 | 百济神州(广州)生物科技有限公司 | 抗pd1抗体及其作为治疗剂与诊断剂的用途 |
| JP6275846B2 (ja) * | 2013-12-05 | 2018-02-07 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 求電子性官能基を有するヘテロアリールピリドン及びアザ−ピリドン化合物 |
| KR102003754B1 (ko) | 2014-07-03 | 2019-07-25 | 베이진 엘티디 | Pd-l1 항체와 이를 이용한 치료 및 진단 |
| WO2016079669A1 (en) * | 2014-11-19 | 2016-05-26 | Novartis Ag | Labeled amino pyrimidine derivatives |
| ES2928164T3 (es) | 2015-10-19 | 2022-11-15 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| CA3005727A1 (en) | 2015-11-19 | 2017-05-26 | Incyte Corporation | Substituted 2-methylbiphenyl-3-yl heterocyclic compounds and pharmaceutical compositions thereof useful as immunomodulators |
| WO2017106634A1 (en) * | 2015-12-17 | 2017-06-22 | Incyte Corporation | N-phenyl-pyridine-2-carboxamide derivatives and their use as pd-1/pd-l1 protein/protein interaction modulators |
| PE20230731A1 (es) | 2015-12-22 | 2023-05-03 | Incyte Corp | Compuestos heterociclicos como inmunomoduladores |
| AR108396A1 (es) | 2016-05-06 | 2018-08-15 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| ES2905980T3 (es) | 2016-05-26 | 2022-04-12 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| KR20230109185A (ko) | 2016-06-07 | 2023-07-19 | 자코바이오 파마슈티칼스 컴퍼니 리미티드 | Shp2 억제제로서 유용한 신규한 헤테로환형 유도체 |
| PE20190731A1 (es) | 2016-06-20 | 2019-05-23 | Incyte Corp | Compuestos heterociclicos como inmunomoduladores |
| CN109475536B (zh) | 2016-07-05 | 2022-05-27 | 百济神州有限公司 | 用于治疗癌症的PD-l拮抗剂和RAF抑制剂的组合 |
| ES2930092T3 (es) | 2016-07-14 | 2022-12-07 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| JP7402685B2 (ja) | 2016-08-16 | 2023-12-21 | ベイジーン スウィッツァーランド ゲーエムベーハー | （ｓ）－７－（１－アクリロイルピペリジン－４－イル）－２－（４－フェノキシフェニル）－４，５，６，７－テトラ－ヒドロピラゾロ［１，５－ａ］ピリミジン－３－カルボキサミドの結晶形、その調製、及びその使用 |
| WO2018033135A1 (en) | 2016-08-19 | 2018-02-22 | Beigene, Ltd. | Use of a combination comprising a btk inhibitor for treating cancers |
| MA46045A (fr) | 2016-08-29 | 2021-04-28 | Incyte Corp | Composés hétérocycliques utilisés comme immunomodulateurs |
| WO2018053437A1 (en) | 2016-09-19 | 2018-03-22 | Mei Pharma, Inc. | Combination therapy |
| BR112019012957A2 (pt) | 2016-12-22 | 2019-11-26 | Incyte Corp | derivados de tetra-hidroimidazo[4,5-c]piridina como indutores de internalização de pd-l1 |
| MY197635A (en) | 2016-12-22 | 2023-06-29 | Incyte Corp | Benzooxazole derivatives as immunomodulators |
| ES2899402T3 (es) | 2016-12-22 | 2022-03-11 | Incyte Corp | Derivados de piridina como inmunomoduladores |
| EP3558989B1 (de) | 2016-12-22 | 2021-04-14 | Incyte Corporation | Triazolo[1,5-a]pyridin-derivate als immunmodulatoren |
| EP3573989A4 (de) | 2017-01-25 | 2020-11-18 | Beigene, Ltd. | Kristalline formen von (s)-7-(1-(but-2-ynoyl)-piperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-carboxamid, herstellung und verwendungen davon |
| JP6878615B2 (ja) | 2017-03-23 | 2021-05-26 | ジャコバイオ ファーマスーティカルズ カンパニー リミテッドＪａｃｏｂｉｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏ．， Ｌｔｄ． | Ｓｈｐ２阻害剤として有用な新規な複素環式誘導体 |
| EP3645569A4 (de) | 2017-06-26 | 2021-03-24 | BeiGene, Ltd. | Immuntherapie für leberzellkarzinom |
| US11377449B2 (en) | 2017-08-12 | 2022-07-05 | Beigene, Ltd. | BTK inhibitors with improved dual selectivity |
| WO2019108795A1 (en) | 2017-11-29 | 2019-06-06 | Beigene Switzerland Gmbh | Treatment of indolent or aggressive b-cell lymphomas using a combination comprising btk inhibitors |
| HRP20230090T1 (hr) | 2018-03-30 | 2023-03-17 | Incyte Corporation | Heterociklički spojevi kao imunomodulatori |
| CN112752756A (zh) | 2018-05-11 | 2021-05-04 | 因赛特公司 | 作为PD-L1免疫调节剂的四氢-咪唑并[4,5-c]吡啶衍生物 |
| US11753406B2 (en) | 2019-08-09 | 2023-09-12 | Incyte Corporation | Salts of a PD-1/PD-L1 inhibitor |
| AR120109A1 (es) | 2019-09-30 | 2022-02-02 | Incyte Corp | Compuestos de pirido[3,2-d]pirimidina como inmunomoduladores |
| PE20230407A1 (es) | 2019-11-11 | 2023-03-07 | Incyte Corp | Sales y formas cristalinas de un inhibidor de pd-1/pd-l1 |
| WO2022099075A1 (en) | 2020-11-06 | 2022-05-12 | Incyte Corporation | Crystalline form of a pd-1/pd-l1 inhibitor |
| US11780836B2 (en) | 2020-11-06 | 2023-10-10 | Incyte Corporation | Process of preparing a PD-1/PD-L1 inhibitor |
| MX2023005362A (es) | 2020-11-06 | 2023-06-22 | Incyte Corp | Proceso para hacer un inhibidor de proteina de muerte programada 1 (pd-1)/ligando de muerte programada 1 (pd-l1) y sales y formas cristalinas del mismo. |
| US11786531B1 (en) | 2022-06-08 | 2023-10-17 | Beigene Switzerland Gmbh | Methods of treating B-cell proliferative disorder |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1144390A2 (de) * | 1999-01-22 | 2001-10-17 | Amgen Inc., | Kinasehemmer |
| JP2005255675A (ja) * | 2004-02-09 | 2005-09-22 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| RU2423351C2 (ru) | 2004-12-16 | 2011-07-10 | Вертекс Фармасьютикалз Инкорпорейтед | Пирид-2-оны, применимые как ингибиторы протеинкиназ семейства тес для лечения воспалительных, пролиферативных и иммунологически-опосредованных заболеваний |
-
2007
- 2007-09-10 AR ARP070103989A patent/AR063707A1/es unknown
- 2007-09-10 PE PE2007001210A patent/PE20081370A1/es not_active Application Discontinuation
- 2007-09-11 KR KR1020097007473A patent/KR101444481B1/ko active IP Right Grant
- 2007-09-11 TW TW096133935A patent/TWI398439B/zh not_active IP Right Cessation
- 2007-09-11 JP JP2009527626A patent/JP5563301B2/ja active Active
- 2007-09-11 RU RU2009113692/04A patent/RU2009113692A/ru not_active Application Discontinuation
- 2007-09-11 CN CNA200780041899XA patent/CN101605778A/zh active Pending
- 2007-09-11 DE DE602007012281T patent/DE602007012281D1/de active Active
- 2007-09-11 AT AT07842267T patent/ATE496909T1/de not_active IP Right Cessation
- 2007-09-11 MX MX2009002651A patent/MX2009002651A/es not_active Application Discontinuation
- 2007-09-11 ES ES07842267T patent/ES2363269T3/es active Active
- 2007-09-11 WO PCT/US2007/078185 patent/WO2008033857A2/en active Application Filing
- 2007-09-11 AU AU2007296563A patent/AU2007296563B2/en not_active Ceased
- 2007-09-11 EP EP07842267A patent/EP2079726B1/de active Active
- 2007-09-11 CL CL200702642A patent/CL2007002642A1/es unknown
- 2007-09-11 BR BRPI0716914-0A patent/BRPI0716914A2/pt not_active Application Discontinuation
- 2007-09-11 CA CA2661951A patent/CA2661951C/en not_active Expired - Fee Related
-
2009
- 2009-02-26 IL IL197264A patent/IL197264A0/en unknown
- 2009-03-06 ZA ZA200901634A patent/ZA200901634B/xx unknown
- 2009-04-01 CO CO09033749A patent/CO6180464A2/es not_active Application Discontinuation
- 2009-04-03 CR CR10709A patent/CR10709A/es unknown
- 2009-04-06 MA MA31767A patent/MA31276B1/fr unknown
- 2009-04-07 EC EC2009009238A patent/ECSP099238A/es unknown
- 2009-04-07 NO NO20091426A patent/NO20091426L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MA31276B1 (fr) | 2010-04-01 |
| ECSP099238A (es) | 2009-07-31 |
| JP5563301B2 (ja) | 2014-07-30 |
| TWI398439B (zh) | 2013-06-11 |
| KR101444481B1 (ko) | 2014-09-24 |
| CR10709A (es) | 2009-07-14 |
| EP2079726A2 (de) | 2009-07-22 |
| RU2009113692A (ru) | 2010-10-20 |
| BRPI0716914A2 (pt) | 2013-11-05 |
| MX2009002651A (es) | 2009-03-26 |
| EP2079726B1 (de) | 2011-01-26 |
| AU2007296563B2 (en) | 2013-01-10 |
| ZA200901634B (en) | 2009-12-30 |
| WO2008033857A3 (en) | 2008-06-05 |
| WO2008033857A2 (en) | 2008-03-20 |
| ES2363269T3 (es) | 2011-07-28 |
| AR063707A1 (es) | 2009-02-11 |
| ATE496909T1 (de) | 2011-02-15 |
| CA2661951A1 (en) | 2008-03-20 |
| IL197264A0 (en) | 2009-12-24 |
| CL2007002642A1 (es) | 2008-07-18 |
| JP2010502750A (ja) | 2010-01-28 |
| PE20081370A1 (es) | 2008-11-28 |
| CA2661951C (en) | 2014-11-18 |
| TW200829567A (en) | 2008-07-16 |
| CN101605778A (zh) | 2009-12-16 |
| CO6180464A2 (es) | 2010-07-19 |
| KR20090074192A (ko) | 2009-07-06 |
| NO20091426L (no) | 2009-06-10 |
| AU2007296563A1 (en) | 2008-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602007012281D1 (de) | Substituierte amide, herstellungsverfahren und verwendungsverfahren | |
| NO20091424L (no) | Substituerte amider, fremgangsmåte for fremstilling derav og anvendelse derav | |
| IL185785A0 (en) | Certain substituted amides, method of making, and method of use thereof | |
| DE602006019900D1 (de) | Injektionsverfahren und gerät | |
| DE602008003068D1 (de) | Vorrichtungsanschluss, Anschlussverfahren und Vorrichtung dafür | |
| DE602006011600D1 (de) | Audiocodierungseinrichtung und audiocodierungsverfahren | |
| IL192965A0 (en) | Amido compounds and their use as pharmaceuticals | |
| DE602006002963D1 (de) | Wickelverfahren und spuleneinheit | |
| DE602006014957D1 (de) | Audiocodierungseinrichtung und audiocodierungsverfahren | |
| DE602007002032D1 (de) | Messvorrichtung und Messverfahren | |
| IL191035A0 (en) | Pharmaceutical use of substituted amides | |
| IL191034A0 (en) | Pharmaceutical use of substituted amides | |
| DE602006008061D1 (de) | Kommunikationsgerät und Kommunikationsverfahren | |
| ATE500227T1 (de) | Amidderivate | |
| DE602006001473D1 (de) | Druckvorrichtung und Druckverfahren | |
| FI20060955A0 (fi) | Sakeutuslaite ja -menetelmä | |
| BRPI0811137A2 (pt) | Método, e, dispositivo de usuário | |
| BRPI0906101A2 (pt) | "métodos de procuração de diamina e de poliamida" | |
| DE602007011198D1 (de) | Projektionsvorrichtung und projektionsverfahren | |
| FI20075686A0 (fi) | Konfigurointimenetelmä ja -laite | |
| EP2404909A4 (de) | Amidthiazolderivat, verfahren zu seiner herstellung und verwendung | |
| EP2281810A4 (de) | Amidverbindungen sowie verfahren zu ihrer herstellung und anwendungen davon | |
| EP2143709A4 (de) | Amidverbindung und ihre verwendung | |
| EP2151431A4 (de) | Amidverbindung und ihre verwendung | |
| EP2245020A4 (de) | Thiazolylidinharnstoff- und amidderivate und verfahren zur anwendung davon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R081 | Change of applicant/patentee |
Ref document number: 2079726 Country of ref document: EP Owner name: GILEAD CONNECTICUT, INC. (N.D.GES.D. STAATES D, US Free format text: FORMER OWNER: CGI PHARMACEUTICALS, INC., BRANFORD, US Effective date: 20121025 |
|
| R082 | Change of representative |
Ref document number: 2079726 Country of ref document: EP Representative=s name: BOEHMERT & BOEHMERT, DE Effective date: 20121025 |